GE HealthCare Raises 2026 Guidance as Third-Quarter Results Top Estimates
Revenue rose 7.2% year over year to $5.51 billion, while organic orders grew 4%.

GE HealthCare Technologies Inc. raised its full-year guidance Wednesday after third-quarter non-GAAP earnings per share topped estimates by 14 cents and revenue exceeded estimates by $160 million.
Revenue reached $5.51 billion, up 7.2% from a year earlier. Non-GAAP earnings per share was $1.34.
Organic orders grew 4%. The company reported a book-to-bill ratio of 1.03 and a backlog of $23.7 billion.
Before the results, GE HealthCare had reaffirmed its 2026 targets for organic revenue growth of 3% to 4%, free cash flow of about $1.6 billion, adjusted earnings per share of $4.80 to $5 and an adjusted EBIT margin of 15.4% to 15.7%, as detailed in its Q3 earnings preview.
The company’s earnings call is scheduled for Wednesday at 8:30 a.m. ET (12:30 p.m. UTC).